Skin Aging
Conditions
Brief summary
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
Interventions
DRUGKinerase Pro+Therapy Line day repair, serum, night repair
DRUGKinerase Pro+Therapy Line Ultra rich day repair
DRUGLubriDerm
Sponsors
Innovative Medical
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE
Eligibility
Sex/Gender
FEMALE
Age
35 Years to 55 Years
Inclusion criteria
* Female patients 35-55 years of age with at least moderate signs of facial aging * Written informed consent * Likely to complete all study visits and follow study protocol
Exclusion criteria
* Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements * Known hypersensitivity to any study product or their components * Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures) * Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments) * Planned facial procedures during the study (microdermabrasion, facials, etc) o Botox and fillers cannot be used during the trial or for 3 months prior to study entry * Recent (within 60 days) or concurrent participation in another clinical trial * Concomitant topical or systemic therapy that my interfere with study measurements or outcomes * Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens * Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study * Wearing of cosmetics during study visits
Countries
United States
Outcome results
None listed